INTRODUCTION: Prolonged recovery time (RT) affects patient's quality-of-life adversely. Shorter dialysis RT in home haemodialysis (HHD) noted in observational studies has been attributed to intensive dialysis regimens. Home patients adopt different haemodialysis (HD) schedules. There is insufficient literature on RT in HHD patients receiving different HD schedules. METHODS: Data was prospectively collected for BASIC-HHD study, a multicentre study of home and hospital HD across five tertiary centres in the UK. Two hundred and eighty-eight patients answered the question, 'how long does it take for you to recover from a haemodialysis session?' Ninety-one patients (31.8%) of study population performed HHD. Participants completed neuropsychometric tests and depression and anxiety screening inventories. RESULTS: Recovery time is longest amongst 'in-centre' HD recipients (Mean 193 min; SD 295.37) and significantly higher than the mean RT of home HD recipients (Mean 67.3 min; SD 86.8). Within the home setting, RT was not significantly different between the intensive HD and conventional HD (67.8 vs 66.5 min; P > 0.05) groups but higher residual urine volumes in the standard home group had significantly shorter RT. Location of HD, not intensity, remained significant (P = 0.001) in the unadjusted and adjusted multivariable analysis. Longer RT was associated with female gender, unemployed or retired 'work' status, 'non-white' ethnicity, lower predialysis systolic blood pressure and greater depression screening score. CONCLUSIONS: Home-based HD and higher residual urine volumes are significantly associated with shorter RT. This home advantage for RT may be sustained by preserving residual renal function (in early stages) and increasing HD intensity (in later stages) of dialysis therapy.
INTRODUCTION: Prolonged recovery time (RT) affects patient's quality-of-life adversely. Shorter dialysis RT in home haemodialysis (HHD) noted in observational studies has been attributed to intensive dialysis regimens. Home patients adopt different haemodialysis (HD) schedules. There is insufficient literature on RT in HHDpatients receiving different HD schedules. METHODS: Data was prospectively collected for BASIC-HHD study, a multicentre study of home and hospital HD across five tertiary centres in the UK. Two hundred and eighty-eight patients answered the question, 'how long does it take for you to recover from a haemodialysis session?' Ninety-one patients (31.8%) of study population performed HHD. Participants completed neuropsychometric tests and depression and anxiety screening inventories. RESULTS: Recovery time is longest amongst 'in-centre' HD recipients (Mean 193 min; SD 295.37) and significantly higher than the mean RT of home HD recipients (Mean 67.3 min; SD 86.8). Within the home setting, RT was not significantly different between the intensive HD and conventional HD (67.8 vs 66.5 min; P > 0.05) groups but higher residual urine volumes in the standard home group had significantly shorter RT. Location of HD, not intensity, remained significant (P = 0.001) in the unadjusted and adjusted multivariable analysis. Longer RT was associated with female gender, unemployed or retired 'work' status, 'non-white' ethnicity, lower predialysis systolic blood pressure and greater depression screening score. CONCLUSIONS: Home-based HD and higher residual urine volumes are significantly associated with shorter RT. This home advantage for RT may be sustained by preserving residual renal function (in early stages) and increasing HD intensity (in later stages) of dialysis therapy.
Authors: Jessica Fitzpatrick; Stephen M Sozio; Bernard G Jaar; Michelle M Estrella; Dorry L Segev; Tariq Shafi; Jose M Monroy-Trujillo; Rulan S Parekh; Mara A McAdams-DeMarco Journal: Kidney360 Date: 2021-07-13
Authors: Murilo Guedes; Roberto Pecoits-Filho; Juliana El Ghoz Leme; Yue Jiao; Jochen G Raimann; Yuedong Wang; Peter Kotanko; Thyago Proença de Moraes; Ravi Thadhani; Franklin W Maddux; Len A Usvyat; John W Larkin Journal: BMC Nephrol Date: 2020-12-07 Impact factor: 2.388
Authors: Jacqueline Watt; Jessica Fitzpatrick; Stephen M Sozio; Bernard G Jaar; Michelle M Estrella; Larisa G Tereshchenko; Jose M Monroy-Trujillo; Michael Walsh; Rulan S Parekh Journal: BMC Nephrol Date: 2022-01-27 Impact factor: 2.388
Authors: Dana Kendzia; Federica Lima; Jacek Zawierucha; Ellen Busink; Christian Apel; Jacek Stanislaw Malyszko; Pawel Zebrowski; Jolanta Malyszko Journal: J Clin Med Date: 2022-07-18 Impact factor: 4.964
Authors: Eran Y Bellin; Alice M Hellebrand; Steven M Kaplan; Jordan G Ledvina; William T Markis; Nathan W Levin; Allen M Kaufman Journal: Hemodial Int Date: 2022-04-06 Impact factor: 1.543